Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes
Top Cited Papers
Open Access
- 15 February 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 95 (4) , 1386-1392
- https://doi.org/10.1182/blood.v95.4.1386.004k22_1386_1392
Abstract
The role of the cellular immune response in human T-cell leukemia virus type I (HTLV-I) infection is not fully understood. A persistently activated cytotoxic T lymphocyte (CTL) response to HTLV-I is found in the majority of infected individuals. However, it remains unclear whether this CTL response is protective or causes tissue damage. In addition, several observations paradoxically suggest that HTLV-I is transcriptionally silent in most infected cells and, therefore, not detectable by virus-specific CTLs. With the use of a new flow cytometric procedure, we show here that a high proportion of naturally infected CD4+ peripheral blood mononuclear cells (PBMC) (between 10% and 80%) are capable of expressing Tax, the immunodominant target antigen recognized by virus-specific CTLs. Furthermore, we provide direct evidence that autologous CD8+ T cells rapidly kill CD4+ cells naturally infected with HTLV-I and expressing Tax in vitro by a perforin-dependent mechanism. Consistent with these observations, we observed a significant negative correlation between the frequency of Tax11-19-specific CD8+ T cells and the percentage of CD4+ T cells in peripheral blood of patients infected with HTLV-I. Those results are in accordance with the view that virus-specific CTLs participate in a highly efficient immune surveillance mechanism that persistently destroys Tax-expressing HTLV-I-infected CD4+ T cells in vivo.Keywords
This publication has 38 references indexed in Scilit:
- Genetic control and dynamics of the cellular immune response to the human T–cell leukaemia virus, HTLV–IPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- HUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASESAnnual Review of Immunology, 1997
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytesAnnals of Neurology, 1996
- Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virusJournal of General Virology, 1995
- An HTLV-I Vaccine: Why, How, for Whom?AIDS Research and Human Retroviruses, 1993
- REGULATION OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATIONAnnual Review of Microbiology, 1991
- Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological diseaseNature, 1990
- Close association between interleukin 2 receptor mRNA expression and human T cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T cell leukemia patients.Journal of Clinical Investigation, 1988
- Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic systemNature, 1974